Acid-suppressing therapies and subsite-specific risk of stomach cancer

BACKGROUND: Associations of stomach cancer risk with histamine type-2 receptor antagonists (H(2)RA) and proton-pump inhibitors (PPI) are controversial. We hypothesised that proximal extension of Helicobacter pylori infection from acid suppression would disproportionately increase cancers at proximal...

Descripción completa

Detalles Bibliográficos
Autores principales: Wennerström, E Christina M, Simonsen, Jacob, Camargo, M Constanza, Rabkin, Charles S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418456/
https://www.ncbi.nlm.nih.gov/pubmed/28350791
http://dx.doi.org/10.1038/bjc.2017.84

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418456/
https://www.ncbi.nlm.nih.gov/pubmed/28350791
http://dx.doi.org/10.1038/bjc.2017.84

Ejemplares similares